E2F1 and colorectal carcinoma: Thus, the presence of this SNP can be considered a protective factor against CRC; however, the authors also observed that the rs35301225 CA genotype in miR-34a is associated with increased E2F1 expression, which in turn is associated with worse survival in CRC patients [45].